FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to an agent for treating malignant growths containing S,N-substituted derivative of isothiourea of general formula: 
, wherein R1=C2H5; i-C3H7; R2=C2H5; i-C3H7; The compounds are able to slow the tumour growth and to suppress the metastatic processes.
EFFECT: new agent has no undesirable side effects specific for the antiangiogenic anticancer agents with the VEGF inhibitory mechanism having the same pharmacological action.
4 cl, 4 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPLEX ANTIANGIOGENIC AND HYPOXIA-TARGETED ANTITUMOR AGENT | 2022 |
|
RU2804771C1 |
| AGENT FOR TARGETED THERAPY OF MALIGNANT GROWTHS | 2018 |
|
RU2699558C2 |
| COMPLEX ANTI-TUMORAL PRODUCT | 2020 |
|
RU2751776C2 |
| ANGIOGENESIS INHIBITOR, ANTI-ANGIOGENIC PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR TREATMENT OF MALIGNANT NEOPLASM | 2005 |
|
RU2287341C1 |
| METHOD FOR TREATING MALIGNANT NEOPLASMS | 2006 |
|
RU2320364C1 |
| CORRECTIVE AGENT FOR PARANEOPLASTIC DAMAGES AND TOXIC EFFECTS OF CYTOSTATIC POLYCHEMOTHERAPY | 2008 |
|
RU2385324C1 |
| NEW CHEMICAL COMPOUND OF L-LYSINE 9-OXOACRIDINYL-10-ACETATE, STIMULATING PRODUCTION OF INTERLEUKIN-24 AND TUMOUR NECROSIS FACTOR - BETA | 2019 |
|
RU2730530C1 |
| N-[3-OXO-LUPANO-28-YL]-MORPHOLINE - AGENT FOR CORRECTION OF CYTOTOXIC LIVER DAMAGES WITH ANTITUMOUR AND ANTIMETASTATIC ACTIVITY | 2011 |
|
RU2461563C1 |
| N-[3-OXO-LUPANO-28-YL]-PIPERIDINE - AGENT HAVING ANTI-TUMOUR, ANTI-METASTATIC, ANTI-INFLAMMATORY AND CYTOPROTECTIVE ACTIVITY | 2011 |
|
RU2466136C1 |
| ANTI-INFLAMMATORY MEDICATION WITH ANTICOAGULANT, ANTITUMOUR AND ANTIMETASTETIC ACTIVITY | 2009 |
|
RU2412712C1 |
